Lipella Pharmaceuticals Inc. Operating Lease, Right-of-Use Asset, Amortization Expense
Lipella Pharmaceuticals Inc. (LIPO) reported Operating Lease, Right-of-Use Asset, Amortization Expense of $538 for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-31.
Discontinued › Cash Flow
us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense · last filed 2023-03-31
- Lipella Pharmaceuticals Inc. operating lease, right-of-use asset, amortization expense for fiscal 2022 was $538.00, a 71.43% decline from fiscal 2021.
- Lipella Pharmaceuticals Inc. operating lease, right-of-use asset, amortization expense for fiscal 2021 was $1.88K.
| Period end | Operating Lease, Right-of-Use Asset, Amortization Expense 12 month |
|---|---|
| 2022-12-31 | $538.00 10-K · filed 2023-03-31 |
| 2021-12-31 | $1.88K 10-K · filed 2023-03-31 |